Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06268236Not ApplicableRecruiting

Electro-acupuncture to Treat Disorder of Consciousness

Role: lead

NCT04816201Not ApplicableRecruiting

Electroacupuncture to Assist Ventilator Weaning in Severe Stroke

Role: lead

NCT04923802Terminated

Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

Role: collaborator

NCT02490020Phase 1Unknown

A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death

Role: collaborator

All 4 trials loaded